MFEC:PA:PA-Lyxor Core MSCI EMU (DR) UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 13.596

Change

-0.10 (-0.70)%

Market Cap

USD 0.48B

Volume

272.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-21 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.52 (+1.20%)

USD 66.11B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-1.00 (-0.20%)

USD 11.38B
WRD:PA HSBC ETFs Public Limited Compa..

-0.04 (-0.13%)

USD 9.27B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-0.62 (-0.26%)

USD 7.87B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+1.45 (+0.32%)

USD 7.28B
HHH:PA HSBC ETFs Public Limited Compa..

-0.09 (-0.17%)

USD 6.91B
WLD:PA Lyxor UCITS MSCI World D-EUR

-0.17 (-0.05%)

USD 6.48B
LCWD:PA Multi Units Luxembourg - Lyxor..

-0.02 (-0.09%)

USD 5.45B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

-0.56 (-0.15%)

USD 4.39B
500U:PA Amundi Index Solutions - Amund..

-0.39 (-0.37%)

USD 4.25B

ETFs Containing MFEC:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.52% 59% D- 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.52% 60% D- 67% D+
Trailing 12 Months  
Capital Gain 15.89% 58% F 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.89% 55% F 84% B
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 8.47% 61% D- 62% D
Dividend Return 8.47% 60% D- 61% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.19% 72% C 85% B
Risk Adjusted Return 103.37% 99% N/A 96% N/A
Market Capitalization 0.48B 68% D+ 69% C-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike